Intriguingly, platinum induced activation of both ERK1/2 and AKT was only observed in malignant ascites derived cancer cells of platinum-resistant relapse patients but not from therapy-naive or platinum sensitive relapse patients. The gene discussed is MAPK3; the disease is cancer.